跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,830 条关于
“Osteogenesis Imperfecta Foundation”
全部
4,830
临床试验
258
药物
59
机构
474
资讯
4,039
11个月前
NIH Awards $15.6 Million to Advance Research on Rare Bone and Metabolic Disorders
去年
NextCure's NC605 Shows Promise in Treating Osteogenesis Imperfecta with Enhanced Bone Quality
去年
Ultragenyx's Setrusumab Receives FDA Breakthrough Therapy Designation for Osteogenesis Imperfecta
2年前
Setrusumab Shows Sustained Fracture Reduction in Osteogenesis Imperfecta Patients
10个月前
BOOST Pharma Secures €3.1 Million to Advance Stem Cell Therapy for Osteogenesis Imperfecta
10个月前
Stem Cell Therapy Shows 78% Fracture Reduction in Children with Osteogenesis Imperfecta
8个月前
Setrusumab Phase 3 Trials in Osteogenesis Imperfecta Show Mixed Results Across Age Groups
9个月前
FDA Grants Medivir's MIV-711 Orphan Drug Designation for Osteogenesis Imperfecta Treatment
去年
Setrusumab Receives FDA Breakthrough Therapy Designation for Osteogenesis Imperfecta
去年
NextCure's Anti-Siglec-15 Antibody NC605 Shows Promise for Osteogenesis Imperfecta Treatment in Preclinical Study
第 1 页，共 404 页
上一页
下一页
